BIOBIN (Cytarabine 1g/10ml) 10ml INTRAVENOUS INJECTION.
Generic name: Cytarabine
Brand name: zydus celexa
Class: Antimetabolite, Chemotherapy Agent.
Pack size: 10ml
Form: Injection
Strength: 1g
Amount: ₦‎11,500

Description: Biobin (Cytarabine Injection) is a chemotherapy drug used to treat certain types of blood cancers such as leukaemia, including acute myeloid leukaemia (AML) and acute lymphoblastic leukaemia (ALL). Cytarabine works by inhibiting the synthesis of DNA, leading to the destruction of cancerous cells. This injection is typically administered intravenously (IV).

Key features:
• For intravenous injection (IV use)
• Used for the treatment of acute myeloid leukaemia (AML), acute lymphoblastic leukaemia (ALL), and other haematological malignancies.
• Contains 1g of the active ingredient, Cytarabine.

Side Effects:
• Nausea and vomiting
• Hair loss (alopecia)
• Bone marrow suppression (low blood cell counts)
• Mouth sores
• Fever and infections due to weakened immune system
• Diarrhoea
• Liver toxicity

Caution:
• Should only be administered by a healthcare professional in a controlled medical environment.
• Regular blood tests and monitoring are necessary to check blood cell counts and organ function during treatment.
• Not suitable for use during pregnancy or breastfeeding due to the risk of harm to the baby.
• Patients should be monitored for signs of infection due to bone marrow suppression.
• Use with caution in patients with liver, kidney, or lung disease.
• Inform your healthcare provider of any other medications being taken as Cytarabine may interact with other drugs.
• Store at a temperature below 30°C and protect from light.